JP2024522148A5 - - Google Patents

Info

Publication number
JP2024522148A5
JP2024522148A5 JP2023574638A JP2023574638A JP2024522148A5 JP 2024522148 A5 JP2024522148 A5 JP 2024522148A5 JP 2023574638 A JP2023574638 A JP 2023574638A JP 2023574638 A JP2023574638 A JP 2023574638A JP 2024522148 A5 JP2024522148 A5 JP 2024522148A5
Authority
JP
Japan
Prior art keywords
psoriasis
nucleic acid
acid molecule
trim65
ifih1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574638A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522148A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/032859 external-priority patent/WO2022261341A1/en
Publication of JP2024522148A publication Critical patent/JP2024522148A/ja
Publication of JP2024522148A5 publication Critical patent/JP2024522148A5/ja
Pending legal-status Critical Current

Links

JP2023574638A 2021-06-10 2022-06-09 インターフェロン誘導ヘリカーゼcドメイン1(ifih1)阻害剤による乾癬の治療 Pending JP2024522148A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209075P 2021-06-10 2021-06-10
US63/209,075 2021-06-10
PCT/US2022/032859 WO2022261341A1 (en) 2021-06-10 2022-06-09 Treatment of psoriasis with interferon induced helicase c domain 1 (ifih1) inhibitors

Publications (2)

Publication Number Publication Date
JP2024522148A JP2024522148A (ja) 2024-06-11
JP2024522148A5 true JP2024522148A5 (https=) 2025-06-05

Family

ID=82404070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574638A Pending JP2024522148A (ja) 2021-06-10 2022-06-09 インターフェロン誘導ヘリカーゼcドメイン1(ifih1)阻害剤による乾癬の治療

Country Status (10)

Country Link
US (1) US12584174B2 (https=)
EP (1) EP4352224A1 (https=)
JP (1) JP2024522148A (https=)
KR (1) KR20240019766A (https=)
CN (1) CN117441019A (https=)
AU (1) AU2022288634A1 (https=)
CA (1) CA3219620A1 (https=)
IL (1) IL308354A (https=)
MX (1) MX2023014586A (https=)
WO (1) WO2022261341A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025202219A1 (en) * 2024-03-25 2025-10-02 Institut National de la Santé et de la Recherche Médicale Mda5 inhibition as a broad defense and healthspan extending strategy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018204764A1 (en) * 2017-05-05 2018-11-08 Camp4 Therapeutics Corporation Identification and targeted modulation of gene signaling networks
BR112022006441A2 (pt) * 2019-10-04 2022-07-05 Univ Michigan Regents Métodos para determinar a capacidade de resposta à terapia antifator de necrose tumoral no tratamento da psoríase
EP3858332A1 (en) * 2020-01-31 2021-08-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bottom-up assembly of synthetic extracellular vesicles

Similar Documents

Publication Publication Date Title
Valluy et al. A coding-independent function of an alternative Ube3a transcript during neuronal development
Gaub et al. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation
Hu et al. miR-191 and miR-135 are required for long-lasting spine remodelling associated with synaptic long-term depression
Liu et al. MicroRNA-141 regulates the expression level of ICAM-1 on endothelium to decrease myocardial ischemia-reperfusion injury
Yu et al. Remote ischemic postconditioning protects the heart by upregulating ALDH2 expression levels through the PI3K/Akt signaling pathway
Zhang et al. Circ-camk4 involved in cerebral ischemia/reperfusion induced neuronal injury
Xu et al. MicroRNA-124 improves functional recovery and suppresses Bax-dependent apoptosis in rats following spinal cord injury
KR20110065522A (ko) 자연 안티센스 전사체가 아포리포단백질-a1로 억제에 의해 아포리포단백-a1 관련된 질환의 치료
JP2013524769A (ja) アポリポタンパク質−a1に対する天然アンチセンス転写物の抑制によるアポリポタンパク質−a1関連疾患の治療
Li et al. RNA interference in vivo in Schistosoma japonicum: Establishing and optimization of RNAi mediated suppression of gene expression by long dsRNA in the intra-mammalian life stages of worms
Sone et al. MicroRNA-mediated attenuation of branched-chain amino acid catabolism promotes ferroptosis in chronic kidney disease
Pattamatta et al. Repeat length increases disease penetrance and severity in C9orf72 ALS/FTD BAC transgenic mice
Liu et al. Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice
JP2023531935A5 (https=)
Hwang et al. CPEB3-dependent increase in GluA2 subunits impairs excitatory transmission onto inhibitory interneurons in a mouse model of fragile X
Singh et al. Histone macroH2A1 is a stronger regulator of hippocampal transcription and memory than macroH2A2 in mice
JP2024522148A5 (https=)
Kuwano et al. Analysis of nitric oxide-stabilized mRNAs in human fibroblasts reveals HuR-dependent heme oxygenase 1 upregulation
Yen et al. The motor neuron m6A repertoire governs neuronal homeostasis and FTO inhibition mitigates ALS symptom manifestation
Jin et al. Disturbed engram network caused by NPTX downregulation underlies aging-related contextual fear memory deficits
Notch et al. Morpholino gene knockdown in adult Fundulus heteroclitus: role of SGK1 in seawater acclimation
Jung et al. Trinucleotide repeat expansion and RNA dysregulation in fragile X syndrome: emerging therapeutic approaches
Ahn et al. Constitutive expression of short hairpin RNA in vivo triggers buildup of mature hairpin molecules
Tripathi et al. Opposing roles of microglial and macrophagic C3ar1 signaling in stress-induced synaptic and behavioral changes
CN112662671A (zh) 靶向SMN2启动子区甲基化位点nt-290所在区域的反义寡核苷酸